Patent · US Active

Treatment of headache using anti-CGRP antibodies

US11639381B2 · kind B2 · utility

5Cited by

38References

15Claims

0Family size

Assignee

H. LUNDBECK A/S · DK

Inventors

Roger K. Cady · Ozark, US
Jeffrey T. L. Smith · Dublin, IE
Joseph Hirman · Bothell, US
Barbara Schaeffler · Seattle, US
Lahar Mehta · Copenhagen, DK

Key dates

Filing date	Feb 18, 2020
Grant date	May 2, 2023
Priority date	—
Expiry date	Feb 18, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for immediate relief of migraine or headache are provided comprising the administration of an anti-CGRP antagonist antibody to a patient in need thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.